Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene

Scandinavian Journal of Immunology

Volumn 68, Issue 6, 2008, Pages 598-606

  Liu, D ^a,b   Niu, Z X ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b Jinan Animal Husbandry and Veterinary Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; DNA VACCINE; HYBRID PROTEIN; NEWCASTLE DISEASE VACCINE; PEPTIDE; PEPTIDE P29; PLASMID DNA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; F GENE; FIBROBLAST CULTURE; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; MOLECULAR CLONING; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECOMBINANT PLASMID; VIRUS GENE;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CLONING, MOLECULAR; COMPLEMENT C3D; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PLASMIDS; POULTRY DISEASES; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; VACCINES, DNA; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 55349119200     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02177.x     Document Type: Article

References (33)

1. Griffioen AW, Rijkers GT, Janssens-Korpela P, Zegers BJ. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect Immun 1991 59 : 1839 45.
2. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996 271 : 348 50.
3. Green TD, Montefiori DC, Ross TM. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 2003 77 : 2046 55.
4. Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2001 20 : 242 8.
5. Li DJ, Wang HM, Li L et al. Gene fusion of molecular adjuvant C3d to hCGβ enhances the anti-hCGβ antibody response in DNA immunization. J Reprod Immunol 2003 60 : 129 41.
6. Wang L, Sunyer JO, Bello LJ. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus. J Virol 2004a 78 : 1616 22.
7. Wang LX, Xu W, Guan QD, Chu YW, Wang Y, Xiong SD. Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization. World J Gastroenterol 2004b 10 : 2072 7.
8. Watanabe I, Ross TM, Tamura S et al. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 2003 21 : 4532 8.
9. Test ST, Mitsuyoshi J, Connolly CC, Lucas AH. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2001 69 : 3031 40.
10. Carter RH, Fearon DT. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J Immunol 1989 143 : 1755 60.
11. Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 1988 141 : 457 63.
12. Haas KM, Toapanta FR, Oliver JA et al. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J Immunol 2004 172 : 5833 7.
13. Liu D, Zhu J-Y, Niu Z-X. Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2. Clin Vaccine immunol 2008 15 : 901 10.
14. Firth MA, Moore DP, Pei YL et al. Cloning of a gene fragment encoding bovine complement component C3d with expression and characterization of derived fusion proteins. Vet Immunol Immunopathol 2006 114 : 61 71.
15. Ling JY, Liu Z, Tong TZ et al. Construction and eukaryotic expression of recombinant plasmid encoding fusion protein of goat complement C3d and foot-and-mouth disease virus VP1. Chin J Biotechnol 2008 24 : 209 13.
16. Mayo MA. Virus taxonomy - Houston 2002. Arch Virol 2002 147 : 1071 6.
17. Millar NS, Chambers P, Emmerson PT. Nucleotide sequence of the fusion and hemaglutinin-neurominidase glycoprotein genes of Newcastle disease virus strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol 1988 69 : 613 20.
18. Nagai Y, Kenk HI, Rott R. Proteolytic cleavage of the viral glycoprotein and its significance for the virulence of Newcastle disease virus. Virology 1976 72 : 494 508.
19. Umino Y, Kohama T, Sato TA, Sugiura A, Klenk HD, Rott R. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glyco-protein associated with proteolytic cleavage. J Gen Virol 1990 71 : 1189 97.
20. Panshin A, Shihmanter E, Weisman Y, Orvell C, Lipkind M. Variability of antigenic epitopes of the fusion protein of Newcastle disease virus. Comp Immunol Microbiol Infect Dis 1998 21 : 51 63.
21. Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci U S A 1985 82 : 4235 9.
22. Esparza I, Becherer JD, Alsenz J et al. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Eur J Immunol 1991 21 : 2829 38.
23. Ma XY, Han JQ, Gao SX, Niu ZX. Study on isolating complement C3d from the chicken serum by the method of immuno affinity chromatography. J NW Sci-Tech Univ Agri Forest 2006 34 : 55 8.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning - A Laboratory Manual, 2nd edn. Woodbury, NY : Cold Spring Harbor Laboratory Press, 1989 : 24 8.
25. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB. Pathotypical and genotypical characterization of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch Virol 2003 148 : 1387 403.
26. Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines. Dev Biol Stand 1998 95 : 43 53.
27. Robinson HL. DNA vaccines for immunodeficiency viruses. AIDS 1997 11 (Suppl. A S109 19.
28. Robinson HL, Pertmer TM. DNA vaccines for viral infections: basic studies and applications. Adv Virus Res 2000 55 : 1 74.
29. Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003 21 : 902 14.
30. Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol 2000 1 : 127 31.
31. Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res Hum Retroviruses 2001 17 : 829 35.
32. Suradhat S, Braun RP, Lewis PJ et al. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization, Vet. Immunol Immunopathol 2001 83 : 79 92.
33. Bergmann-Leitner ES, Leitner WW, Tsokos GC. Complement 3d: from molecular adjuvant to target of immune escape mechanisms. Clin Immunol 2006 121 : 177 85.